<!DOCTYPE html>
<html lang="ja" class="no-js" prefix="og: http://ogp.me/ns#">

<!-- Mirrored from www.taisho.co.jp/global/who_we_are/history.html by HTTrack Website Copier/3.x [XR&CO'2014], Sun, 16 Oct 2022 12:04:48 GMT -->
<head>
<meta charset="UTF-8">
<meta http-equiv="X-UA-Compatible" content="IE=Edge">
<meta name="viewport" content="width=device-width, initial-scale=1">
<meta name="format-detection" content="telephone=no">

<title>History｜Taisho Pharmaceutical Holdings</title>

<meta name="keywords" content="">
<meta name="description" content="View a timeline of major events in the history of the Taisho Pharmaceutical Group, from its foundation in 1912 to the present.">

<meta property="og:title" content="History" />

<meta property="og:description" content="View a timeline of major events in the history of the Taisho Pharmaceutical Group, from its foundation in 1912 to the present." />
<meta property="og:type" content="article" />
<meta property="og:url" content="history.html" />
<meta property="og:site_name" content="Taisho Pharmaceutical Holdings" />

<meta property="og:image" content="../../shared/img/ogp.png" />


<link rel="stylesheet" type="text/css" href="../shared/css/common.css">
<link rel="stylesheet" type="text/css" href="../shared/css/contents_module.css">



<link rel="stylesheet" type="text/css" href="css/history223d.css?20220112">



</head>

<body id="" class="about">
<!-- container -->
<!-- container -->
<div id="container" class="about"> 
	<!-- header --> 
		<header>
		<div id="skipLinkArea" class="forReader">
			<ul>
				<li><a href="#contents">To the text</a></li>
				<li><a href="#globalNav">To main menu</a></li>
				<li><a href="#hdr-menu">To header menu</a></li>
				<li><a href="#footer">To footer menu</a></li>
			</ul>
		</div>
		<div id="header">
			<div id="headerInner">
				<h1><a href="../index.html"><img src="../shared/img/logo_mark.svg" alt="" /><img src="../shared/img/logo.png" alt="Taisho Pharmaceutical Holdings" /></a></h1>
				<nav id="globalArea">
					<dl id="searchArea">
						<dt class="search"><span class="btn"><img src="../shared/img/icn_search.png" alt="Search" /></span></dt>
						<dd>
							<div id="search-section">
								<form name="SS_searchForm" id="SS_searchForm" class="roll" action="https://search.taisho.co.jp/search" method="get" enctype="application/x-www-form-urlencoded">
									<input type="hidden" name="site" value="4L6KNUKF" />
									<input type="hidden" name="charset" value="UTF-8" />
									<input type="hidden" name="design" value="12" />
									<input type="hidden" name="group" value="11" />
									<fieldset>
										<legend>Search</legend>
										<div class="boxSearch">
											<input type="text" name="query" value="" id="SS_searchQuery" maxlength="100" class="search-text" placeholder="What are you looking for?" />
											<input type="image" src="../shared/img/btn_search.png" alt="Search" class="search-btn" />
										</div>
									</fieldset>
								</form>
							</div>
						</dd>
					</dl>
					<dl id="globalNavSet">
						<dt>
							<div><span class="btn">MENU</span><span></span><span></span></div>
						</dt>
						<dd>
							<div>
								<ul id="globalNav">
									<li id="gb-whoweare" class="setDrop"><a href="#gb" class="btnSp btnCat" id="m2ndWhoweare"><span>Who We Are</span></a>
										<div id="gbDrop-whoweare" class="hdr-gbDrop">
											<div class="box m2ndWhoweare">
												<div class="boxInner">
													<div class="ttlArea">
														<p class="sp-dsp-none"><a href="index.html"><span>Who We Are</span></a></p>
														<p class="sp-dsp-block"><a href="#"><span>Who We Are</span></a></p>
														<div class="btnClose"><span></span></div>
													</div>
													<div class="level1">
														<div class="boxList">
															<div class="boxListInner">
																<ul>
																	<li class="sp-dsp-block"><a href="index.html"><span>Who We Are Overview</span></a></li>
																	<li><a href="at_a_glance.html"><span>At a Glance</span></a></li>
																	<li><a href="message_from_management.html"><span>Message from Management</span></a></li>
																	<li><a href="history.html"><span>History</span></a></li>
																	<li><a href="philosophy.html"><span>Philosophy</span></a></li>
																	<li><a href="board_members.html"><span>Board Members</span></a></li>
																	<li><a href="worldwide_locations.html"><span>Worldwide Locations</span></a></li>
																</ul>
															</div>
														</div>
													</div>
												</div>
											</div>
										</div>
									</li>
									<li id="gb-products" class="setDrop"><a href="#gb" class="btnSp btnCat" id="m2ndProducts"><span>Our Products</span></a>
										<div id="gbDrop-products" class="hdr-gbDrop">
											<div class="box m2ndProducts">
												<div class="boxInner">
													<div class="ttlArea">
														<p class="sp-dsp-none"><a href="../our_products/index.html"><span>Our Products</span></a></p>
														<p class="sp-dsp-block"><a href="#"><span>Our Products</span></a></p>
														<div class="btnClose"><span></span></div>
													</div>
													<div class="level1">
														<div class="boxList">
															<div class="boxListInner">
																<ul>
																	<li class="sp-dsp-block"><a href="../our_products/index.html"><span>Our Products Overview</span></a></li>
																	<li><a href="../our_products/lipovitan_series.html"><span>Lipovitan Series</span></a></li>
																	<li><a href="../our_products/pabron_series.html"><span>Pabron Series</span></a></li>
																	<li><a href="../our_products/riup_series.html"><span>RiUP Series</span></a></li>
																	<li><a href="../our_products/counterpain.html"><span>Counterpain<sup>&reg;</sup></span></a></li>
																	<li><a href="../our_products/tempra.html"><span>Tempra<sup>&reg;</sup></span></a></li>
																	<li><a href="../our_products/hapacol.html"><span>Hapacol</span></a></li>
																	<li><a href="../our_products/dafalgan.html"><span>Dafalgan<sup>&reg;</sup></span></a></li>
																	<li><a href="../our_products/efferalgan.html"><span>Efferalgan<sup>&reg;</sup></span></a></li>
																</ul>
															</div>
														</div>
													</div>
												</div>
											</div>
										</div>
									</li>
									<li id="gb-ir" class="setDrop"><a href="#gb" class="btnSp btnCat" id="m2ndIr"><span>Investors</span></a>
										<div id="gbDrop-ir" class="hdr-gbDrop">
											<div class="box m2ndIr">
												<div class="boxInner">
													<div class="ttlArea">
														<p class="sp-dsp-none"><a href="../investors/index.html"><span>Investors</span></a></p>
														<p class="sp-dsp-block"><a href="#"><span>Investors</span></a></p>
														<div class="btnClose"><span></span></div>
													</div>
													<div class="level1">
														<div class="boxList">
															<div class="boxListInner">
																<ul>
																	<li class="sp-dsp-block"><a href="../investors/index.html"><span>Investors Overview</span></a></li>
																	<li><a href="../investors/our_business.html"><span>Our Business</span></a></li>
																</ul>
																<ul>
																	<li><a href="../investors/financial_highlights.html"><span>Financial Highlights</span></a></li>
																	<li><a href="../investors/segment_information.html"><span>Segment Information</span></a></li>
																</ul>
															</div>
														</div>
														<div class="boxList">
															<div class="boxListInner">
																<ul>
																	<li><a href="../investors/financial_results.html"><span>Financial Results</span></a></li>
																	<li><a href="../investors/presentations.html"><span>Presentations</span></a></li>
																	<li><a href="../investors/annual_reports.html"><span>Annual Reports</span></a></li>
																</ul>
																<ul>
																	<li><a href="../investors/stock_information.html"><span>Stock Information</span></a></li>
																</ul>
															</div>
														</div>
													</div>
												</div>
											</div>
										</div>
									</li>
									<li id="gb-sustainability" class="setDrop"><a href="#gb" class="btnSp btnCat" id="m2ndSustainability"><span>Sustainability</span></a>
										<div id="gbDrop-sustainability" class="hdr-gbDrop">
											<div class="box m2ndSustainability">
												<div class="boxInner">
													<div class="ttlArea">
														<p class="sp-dsp-none"><a href="../sustainability/index.html"><span>Sustainability</span></a></p>
														<p class="sp-dsp-block"><a href="#"><span>Sustainability</span></a></p>
														<div class="btnClose"><span></span></div>
													</div>
													<div class="level1">
														<div class="boxList">
															<div class="boxListInner">
																<ul>
																	<li class="sp-dsp-block"><a href="../sustainability/index.html"><span>Sustainability Overview</span></a></li>
																	<li><a href="../sustainability/policy/index.html"><span>Sustainability Policy</span></a></li>
																</ul>
																<ul>
																	<li class="btnLevel2"><a href="#level1"><span>Environment</span></a>
																		<ul class="level2">
																			<li class="first"><a href="#level2"><span>Sustainability</span></a></li>
																			<li class="second"><a href="#level2"><span>Environment</span></a></li>
																			<li class="btnTop"><a href="../sustainability/environment/index.html"><span>Environment <u>Overview</u></span></a></li>
																			<li><a href="../sustainability/environment/policy.html"><span>Policies for Environmental Activities</span></a></li>
																			<li><a href="../sustainability/environment/management.html"><span>Environmental Management</span></a></li>
																			<li><a href="../sustainability/environment/accounting.html"><span>Environmental Accounting</span></a></li>
																			<li><a href="../sustainability/environment/impact.html"><span>Impact of Corporate Activities</span></a></li>
																			<li><a href="../sustainability/environment/objectives_achievements.html"><span>Objectives and Achievements</span></a></li>
																			<li><a href="../sustainability/environment/climate_change.html"><span>Addressing Climate Change</span></a></li>
																			<li><a href="../sustainability/environment/recycling.html"><span>Resource Recycling</span></a></li>
																			<li><a href="../sustainability/environment/pollution.html"><span>Pollution Control</span></a></li>
																			<li><a href="../sustainability/environment/community.html"><span>Community Initiatives</span></a></li>
																			<li><a href="../sustainability/environment/methods_data.html"><span>Methods and Data</span></a></li>
																			<li><a href="../sustainability/environment/reports.html"><span>Environmental Reports</span></a></li>
																		</ul>
																	</li>
																</ul>
															</div>
														</div>
														<div class="boxList">
															<div class="boxListInner">
																<ul>
																	<li class="btnLevel2"><a href="#level1"><span>Social</span></a>
																		<ul class="level2">
																			<li class="first"><a href="#level2"><span>Sustainability</span></a></li>
																			<li class="second"><a href="#level2"><span>Social</span></a></li>
																			<li class="btnTop"><a href="../sustainability/social/index.html"><span>Social <u>Overview</u></span></a></li>
																			<li><a href="../sustainability/social/customers/index.html"><span>Customers</span></a></li>
																			<li><a href="../sustainability/social/partners/index.html"><span>Business Partners</span></a></li>
																			<li><a href="../sustainability/social/employees/index.html"><span>Employees</span></a></li>
																			<li><a href="../sustainability/social/society/index.html"><span>Society</span></a></li>
																		</ul>
																	</li>
																</ul>
																<ul>
																	<li class="btnLevel2"><a href="#level1"><span>Governance</span></a>
																		<ul class="level2">
																			<li class="first"><a href="#level2"><span>Sustainability</span></a></li>
																			<li class="second"><a href="#level2"><span>Governance</span></a></li>
																			<li class="btnTop"><a href="../sustainability/governance/index.html"><span>Governance <u>Overview</u></span></a></li>
																			<li><a href="../sustainability/governance/corporate_governance.html"><span>Corporate Governance</span></a></li>
																			<li><a href="../sustainability/governance/internal_control.html"><span>Internal Control</span></a></li>
																			<li><a href="../sustainability/governance/compliance.html"><span>Compliance</span></a></li>
																			<li><a href="../sustainability/governance/risk_management.html"><span>Risk Management</span></a></li>
																		</ul>
																	</li>
																</ul>
															</div>
														</div>
													</div>
												</div>
											</div>
										</div>
									</li>
								</ul>
								<ul id="menu-sub">
									<li><a href="../news/index.html"><span>News</span></a></li>
									<li><a href="../contact_us/index.html"><span>Contact Us</span></a></li>
								</ul>
							</div>
						</dd>
					</dl>
				</nav>
			</div>
		</div>
	</header>

	<!-- //header --> 
	<!-- topicPath -->
	<div id="topicPath">
		<div class="boxContentsOuter">
			<div class="boxContents">
				<ul id="topicPathMenu">
										<li class="home"><a href="../index.html" class="catFst"><span>Home</span><span class="boxArw"><span></span></span></a>
						<div class="catFst">
							<ul class="catFst">
								<li><a href="index.html">Who We Are</a></li>
								<li><a href="../our_products/index.html">Our Products</a></li>
								<li><a href="../investors/index.html">Investors</a></li>
								<li><a href="../sustainability/index.html">Sustainability</a></li>
							</ul>
						</div>
					</li>

								<li><a href="index.html" class="cat2nd"><span>Who We Are</span><span class="boxArw"><span></span></span></a>
				<div class="cat2nd">
					<ul class="cat2nd">
						<li><a href="at_a_glance.html">At a Glance</a></li>
						<li><a href="message_from_management.html">Message from Management</a></li>
						<li><a href="history.html">History</a></li>
						<li><a href="philosophy.html">Philosophy</a></li>
						<li><a href="board_members.html">Board Members</a></li>
						<li><a href="worldwide_locations.html">Worldwide Locations</a></li>
					</ul>
				</div>
			</li>
					<li class="current"><span><span>History</span></span></li>
				</ul>
			</div>
		</div>
	</div>
	<!-- //topicPath --> 
	<!-- contents -->
	<main id="contents">
	 <section>
	  <div class="boxContentsOuter">
	   <div class="boxContents">
	    <h1>History</h1>
	    <p class="catch"><span class="dsp-inlineBlock">Ever since our founding, we have evolved in response to changing times, always seeking to support the health of our customers.</p>
    </div>
   </div>
	  <div class="boxHistory">
	   <dl id="historyPart1">
	    <dt class="historyPart1">
	     <div class="boxPhoto"><img src="img/history_main01.jpg" alt=""/></div>
	     <div class="boxtxt">
	      <div class="boxContentsOuter">
	       <div class="boxContents">
	        <div class="ttl">
	         <h2><span class="part">Part 1: </span><span class="year">1912 to 1960</span></h2>
			 </div>
	        <div class="historyBox01">
	         <p class="txtCatch">Laying the Foundations</p>
	         <p class="txtLead">Taisho Pharmaceutical was founded in the early twentieth century, a time when medical standards and personal nutrition in Japan were still lacking, to support healthier living and illness prevention through over-the-counter (OTC) drugs.<br>
			 After the end of the Second World War, to play our part in a speedy national recovery, we introduced new technology into our factories to expand our product range to encompass prescription pharmaceuticals as well. With the advent of commercial broadcasting and the television&rsquo;s rapid spread throughout Japan, our commercials featuring our recognizable eagle mark rapidly made Taisho Pharmaceutical a household name.</p>
         </div>
        </div>
       </div>
      </div>
	     <div class="boxIcnBtn">
	      <div class="boxIcnTxt"><span class="txtOpen">OPEN</span><span class="txtClose">CLOSE</span></div>
	      <div class="boxIcn"></div>
      </div>
     </dt>
	    <dd>
	     <div class="boxContentsOuter">
	      <div class="boxContents">
	       <div class="spHistoryBox01"></div>
	       <div class="timeline_box">
	        <ul class="timeline_list">
	         <li class="timeline_left setScMc t1912">
	          <p class="timeline_year"><span class="yearL">1912</span></p>
	          <p class="timeline_ttl"><span class="ttlL">For illness prevention and health promotion</span></p>
	          <p class="timeline_text"><span>Diseases like beriberi and tuberculosis were still relatively common in Japan. Taisho Pharmaceutical was founded with the goal of creating nourishing tonics to prevent these ailments without relying on imports.<br>
			  At the time, medicines were still distributed through commission merchants, but we expanded our sales channels by establishing a unique direct sales system. This strategy became a rock-solid foundation for us in the OTC drug field.</span></p>
	          <p class="timeline_img"><img src="img/history_1912.jpg" alt="The founding of Taisho Pharmaceutical"/></p>
          </li>
	         <li class="timeline_right setScMc t1918">
	          <p class="timeline_year color02"><span class="timeline_text">1918 &nbsp;End of the First World War</span></p>
          </li>
	         <li class="timeline_right setScMc t1927">
	          <p class="timeline_year"><span class="yearL">1927</span></p>
	          <p class="timeline_ttl"><span class="ttlL">Gaining the support of customers by meeting the need for easy-to-consume medicines</span></p>
	          <p class="timeline_text"><span>From its inception, Taisho Pharmaceutical launched one OTC drug after the other. After a succession of products such as nourishing tonics, children's cold medicines and digestive medicines, Taisho Pharmaceutical unveiled a product that would become one of its best-known and longest-selling items: Pabron, a cough suppressant. The name derived from a combination of "Pan-," meaning "all," and "bron" from "bronchitis," hence "for all coughs." The ease with which Pabron could be ingested won it tremendous customer support.</span></p>
	          <p class="timeline_img"><img src="img/history_1927.jpg" alt="Pabron"/></p>
          </li>
	         <li class="timeline_left setScMc t1945 lineL">
	          <p class="timeline_year color02"><span class="timeline_text">1945 &nbsp;End of the World War II</span></p>
          </li>
	         <li class="timeline_left setScMc t1953 lineM">
	          <p class="timeline_year"><span class="yearS">1948</span></p>
	          <p class="timeline_text"><span>Changing the name to Taisho
Pharmaceutical Co., Ltd.</span></p>
          </li>
	         <li class="timeline_left setScMc t1953 lineS">
	          <p class="timeline_year"><span class="yearS">1953</span></p>
	          <p class="timeline_text"><span>Release of Dermarin, a treatment for skin ailments. Its powerful efficacy was noted even by dermatologists and made it a major hit. This also gave us a foothold for our later expansion into prescription pharmaceuticals.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_1953.jpg" alt="Dermarin"/></p>
          </li>
	         <li class="timeline_right setScMc t1955">
	          <p class="timeline_year"><span class="yearM">1955</span></p>
	          <p class="timeline_ttl"><span class="ttlM">Look for the eagle mark</span></p>
	          <p class="timeline_text"><span>Registration of our eagle mark as a trademark and beginning of its use in product advertising. Striking and clear, the eagle mark drove a sharp rise in name recognition for Taisho Pharmaceuticals.</span></p>
	          <p class="timeline_img img_s"><img src="img/history_1955.jpg" alt="Eagle mark"/></p>
          </li>
	         <li class="timeline_left setScMc t1957-01 lineS">
	          <p class="timeline_year"><span class="years">1957</span></p>
	          <p class="timeline_text"><span>Release of our Iris eye drops. This would later be developed into a long-selling series of products.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_1957.jpg" alt="Iris"/></p>
          </li>
	         <li class="timeline_right setScMc t1957-02">
	          <p class="timeline_year"><span class="yearL">1957</span></p>
	          <p class="timeline_ttl"><span class="ttlL">Seizing growth opportunities and manufacturing our first prescription pharmaceuticals</span></p>
	          <p class="timeline_text"><span>As more and more of Japan&rsquo;s population joined the country&rsquo;s new national health insurance scheme, demand for pharmaceuticals soared. Seeing the potential for growth in the industry, we decided to enter the prescription pharmaceuticals market. Building on the success of our dermatological agent Dermalin, we released Psorion, a prescription drug that treated psoriasis.</span></p>
	          <p class="timeline_img"><img src="img/history_1957_02.jpg" alt="Psorion"/></p>
          </li>
	         <li class="timeline_left setScMc t1960 lineS">
	          <p class="timeline_year"><span class="yearS">1960</span></p>
	          <p class="timeline_text"><span>Release of the analgesic Naron. This would become our flagship analgesic brand.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_1960.jpg" alt="Naron"/></p>
          </li>
         </ul>
	        <div class="timelineBrmArw"></div>
        </div>
	       <div class="boxIcnBtn">
	        <div class="boxIcnTxt"><span class="txtClose">CLOSE</span></div>
	        <div class="boxIcn"></div>
        </div>
       </div>
      </div>
     </dd>
    </dl>
	   <dl id="historyPart2">
	    <dt class="historyPart2">
	     <div class="boxPhoto"><img src="img/history_main02.jpg" alt=""/></div>
	     <div class="boxtxt">
	      <div class="boxContentsOuter">
	       <div class="boxContents">
	        <div class="ttl">
	         <h2><span class="part">Part 2: </span><span class="year">1961 to 2001</span></h2>
         </div>
	        <div class="historyBox02">
	         <p class="txtCatch">Pursuing Growth</p>
	         <p class="txtLead">In the 1960s, the &ldquo;Japanese economic miracle&rdquo; filled homes and workplaces with vitality and drove healthcare needs higher. Against this social background, our energy drink, Lipovitan D, was an unprecedented, record-breaking hit. This allowed us to secure an unshakable position as an OTC drug manufacturer.<br>
			 In the 1970s, we responded to extended economic stagnation by revising our sales structure, and in the 1980s we focused on building R&amp;D capacity. By forming relationships with overseas companies and expanding our prescription pharmaceuticals business, we established a position as a comprehensive pharmaceutical company.</p>
         </div>
        </div>
       </div>
      </div>
	     <div class="boxIcnBtn">
	      <div class="boxIcnTxt"><span class="txtOpen">OPEN</span><span class="txtClose">CLOSE</span></div>
	      <div class="boxIcn"></div>
      </div>
     </dt>
	    <dd>
	     <div class="boxContentsOuter">
	      <div class="boxContents">
	       <div class="spHistoryBox02"></div>
	       <div class="timeline_box">
	        <ul class="timeline_list">
	         <li class="timeline_left setScMc t1962">
	          <p class="timeline_year"><span class="yearL">1962</span></p>
	          <p class="timeline_ttl"><span class="ttlL">Becoming an OTC leader by inventing energy drink culture</span></p>
	          <p class="timeline_text"><span>At a time when medicines were generally associated with a bitter taste, Taisho Pharmaceutical won kudos for marketing an energy drink with an appealing flavor. Determined to make products that were more delicious still, we launched Lipovitan D, an energy drink that everyone could enjoy consuming. Lipovitan D was a perfect fit for an era in which health-consciousness and luxury grocery items were taking root among Japanese consumers, and proved a major hit. By inventing the energy drink culture, Taisho Pharmaceutical became a leader in the OTC drug field.</span></p>
	          <p class="timeline_img img_ss"><img src="img/history_1962.jpg" alt="Lipovitan D"/></p>
          </li>
	         <li class="timeline_right setScMc t1963">
	          <p class="timeline_year"><span class="yearM">1963</span></p>
	          <p class="timeline_ttl"><span class="ttlM">Taiwan: Our first overseas market</span></p>
	          <p class="timeline_text"><span>Release of Lipovitan D in Taiwan. Two years later, in 1965, we began exports to Thailand. Southeast Asia became the center of our overseas sales expansion initiatives.</span></p>
	          <p class="timeline_img img_ss"><img src="img/history_1963.jpg" alt="Lipovitan D (Taiwan)"/></p>
          </li>
	         <li class="timeline_left setScMc t1964 lineL">
	          <p class="timeline_year color02"><span class="timeline_text">1964 &nbsp;Tokyo Olympic Games</span></p>
          </li>
	         <li class="timeline_right setScMc t1967">
	          <p class="timeline_year"><span class="yearS">1967</span></p>
	          <p class="timeline_text"><span>Release of the antiphlogistic pain reliever Opyrin, marking our expansion into orthopedics.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_1967.jpg" alt="Opyrin"/></p>
          </li>
	         <li class="timeline_left setScMc t1974 lineM">
	          <p class="timeline_year"><span class="yearM">1974</span></p>
	          <p class="timeline_ttl"><span class="ttlM">Broadening our research focus for global competitiveness</span></p>
	          <p class="timeline_text"><span>Aiming to establish an unshakable foundation in prescription drugs  and become more competitive internationally, we built a comprehensive research center on the grounds of our Omiya Factory. This was the beginning of our biotech research.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_1974.jpg" alt="Comprehensive research center"/></p>
          </li>
	         <li class="timeline_right setScMc t1978">
	          <p class="timeline_year"><span class="yearM">1978</span></p>
	          <p class="timeline_ttl"><span class="ttlM">Addressing the stomach troubles of today</span></p>
	          <p class="timeline_text"><span>Release of the stomach medicine Taisho Kampo, offering relief from a wide range of symptoms. The advertising campaign evoked scenes of festive overindulgence leading to digestive trouble later, which struck a chord with the public and made the product a hit.</span></p>
	          <p class="timeline_img"><img src="img/history_1978.jpg" alt="Taisho Kampo"/></p>
          </li>
	         <li class="timeline_left setScMc t1984 lineM">
	          <p class="timeline_year"><span class="yearM">1984</span></p>
	          <p class="timeline_text"><span>Release of the gastric ulcer treatment Solon, our first foray into internal medicine. Adding efficacy against gastritis in the following year improved sales further.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_1984.jpg" alt="Solon"/></p>
          </li>
	         <li class="timeline_right setScMc t1985">
	          <p class="timeline_year"><span class="yearM">1985</span></p>
	          <p class="timeline_ttl"><span class="ttlM">Establishing the Uehara Memorial Foundation</span></p>
	          <p class="timeline_text"><span>Promising early-career researchers should never be forced to abandon their work for financial reasons: this was the idea that drove us to establish the Uehara Memorial Foundation. In 1985, the foundation began providing assistance for research in order to help the life sciences grow in Japan and promote general health and welfare.</span></p>
          </li>
	         <li class="timeline_left setScMc t1988-01 lineS">
	          <p class="timeline_year"><span class="yearS">1988</span></p>
	          <p class="timeline_text"><span>Founding of Taisho Pharmaceutical California and first energy drink sales in North America.</span></p>
	          <p class="timeline_img img_ss"><img src="img/history_1988.jpg" alt="Lipovitan (North America)"/></p>
          </li>
	         <li class="timeline_right setScMc t1988-02">
	          <p class="timeline_year"><span class="yearS">1988</span></p>
	          <p class="timeline_text"><span>Release of Palux<sup>&reg;</sup> Injection, a peripheral vasodilator effective against chronic arterial occlusion and similar conditions.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_1988_02.jpg" alt="Palux&reg; injection"/></p>
          </li>
	         <li class="timeline_left setScMc t1991">
	          <p class="timeline_year"><span class="yearL">1991</span></p>
	          <p class="timeline_ttl"><span class="ttlL">Developing world-class antibiotics in-house</span></p>
	          <p class="timeline_text"><span>In the early 1990s, creating an original antibiotic to world-class standards was considered a highly difficult feat. Our release of Clarith<sup>&reg;</sup> Tablet, an antibiotic easily meeting these international standards, demonstrated the advanced level of our R&amp;D department.<br>
			  We continued to expand the drug&rsquo;s applications and improve our manufacturing methods after its release, helping it develop into a treatment sold around the world.</span></p>
	          <p class="timeline_img"><img src="img/history_1991.jpg" alt="Clarith&reg; Tablet"/></p>
          </li>
	         <li class="timeline_right setScMc t1992">
	          <p class="timeline_year"><span class="yearS">1992</span></p>
	          <p class="timeline_text"><span>Release of Zena F-II, a drink based on our long-cultivated beverage development techniques combined with crude drug research.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_1992.jpg" alt="Zena F-II"/></p>
          </li>
	         <li class="timeline_left setScMc t1997 lineM">
	          <p class="timeline_year"><span class="yearM">1997</span></p>
	          <p class="timeline_ttl"><span class="ttlM">Improving competitiveness by acquiring powerful brands</span></p>
	          <p class="timeline_text"><span>In order to continue to differentiate ourselves in a maturing market with products offering tradition, trustworthiness, and quality, we embarked on a strategy of acquiring major existing brands. As part of this initiative, we inherited the Colac laxative business from the Procter &amp; Gamble Group.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_1997.jpg" alt="Colac"/></p>
          </li>
	         <li class="timeline_right setScMc t1999-01">
	          <p class="timeline_year"><span class="yearL">1999</span></p>
	          <p class="timeline_ttl"><span class="ttlL">Deregulation boosts Lipovitan D sales</span></p>
	          <p class="timeline_text"><span>Until 1999, energy drinks like Lipovitan D were classified as drugs and sold only in pharmacies and drugstores. With the deregulation of pharmaceutical sales, however, they were reclassified as "quasi-drugs." This made it possible to sell Lipovitan D in convenience stores, supermarkets, and even vending machines, making it even more familiar to consumers.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_1999.jpg" alt="Lipovitan D, sold in vending machines"/></p>
          </li>
	         <li class="timeline_left setScMc t1999-02">
	          <p class="timeline_year"><span class="yearL">1999</span></p>
	          <p class="timeline_ttl"><span class="ttlL">Creating a market with RiUP, Japan&rsquo;s first hair regrowth treatment</span></p>
	          <p class="timeline_text"><span>When American pharmaceutical company Upjohn developed the hair regrowth treatment Minoxidil, we saw its potential immediately. After signing a technology introduction contract in 1985, we spent 14 years on research to develop RiUP, Japan&rsquo;s first hair regrowth treatment for common baldness. RiUP was also Japan&rsquo;s first direct-to-OTC drug, approved for over-the-counter sales with no intervening prescription pharmaceutical phase.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_1999_02.jpg" alt="RiUP"/></p>
          </li>
	         <li class="timeline_right setScMc t2001-01">
	          <p class="timeline_year"><span class="yearS">2001</span></p>
	          <p class="timeline_text"><span>Release of non-steroidal anti-inflammatory analgesic Lorcam<sup>&reg;</sup> Tablet, which used quick-release technology to increase blood concentration faster.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_2001.jpg" alt="Lorcam&reg; Tablet"/></p>
          </li>
	         <li class="timeline_left setScMc t2001-02 lineS">
	          <p class="timeline_year"><span class="yearS">2001</span></p>
	          <p class="timeline_text"><span>Established Taisho R&amp;D USA and began developing prescription pharmaceuticals in the US.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_2001_02.jpg" alt="Taisho R&amp;D USA"/></p>
          </li>
         </ul>
	        <div class="timelineBrmArw"></div>
        </div>
	       <div class="boxIcnBtn">
	        <div class="boxIcnTxt"><span class="txtClose">CLOSE</span></div>
	        <div class="boxIcn"></div>
        </div>
       </div>
      </div>
     </dd>
    </dl>
	   <dl id="historyPart3">
	    <dt class="historyPart3">
	     <div class="boxPhoto"><img src="img/history_main03.jpg" alt=""/></div>
	     <div class="boxtxt">
	      <div class="boxContentsOuter">
	       <div class="boxContents">
	        <div class="ttl">
	         <h2><span class="part">Part 3: </span><span class="year">Since 2002</span></h2>
         </div>
	        <div class="historyBox03">
	         <p class="txtCatch">Evolving Further</p>
	         <p class="txtLead">Against a background of global economic slowdown, the pharmaceutical industry remained active, with major corporations engaging in M&amp;As and restructuring.<br>
			 Amid these developments, we are working to improve our competitiveness both domestically and internationally in a variety of ways: acquiring OTC brands, expanding into health foods and online sales, forming business and capital alliances with other companies, and actively working to expand our OTC drug business in Asia. We continue to develop our self-medication and prescription pharmaceuticals businesses as we evolve into a global company offering total support for health.</p>
         </div>
        </div>
       </div>
      </div>
	     <div class="boxIcnBtn">
	      <div class="boxIcnTxt"><span class="txtOpen">OPEN</span><span class="txtClose">CLOSE</span></div>
	      <div class="boxIcn"></div>
      </div>
     </dt>
	    <dd>
	     <div class="boxContentsOuter">
	      <div class="boxContents">
	       <div class="spHistoryBox03"></div>
	       <div class="timeline_box">
	        <ul class="timeline_list">
	         <li class="timeline_left setScMc t2002 lineM">
	          <p class="timeline_year"><span class="yearM">2002</span></p>
	          <p class="timeline_ttl"><span class="ttlM">No. 1 in cough drops</span></p>
	          <p class="timeline_text"><span>Acquisition of the global brand VICKS from the Procter &amp; Gamble Company in the US. We now have the largest share of the Japanese cough drop category and continue to expand our lineup of VICKS cough drops and other products.</span></p>
	          <p class="timeline_img"><img src="img/history_2002.jpg" alt="VICKS"/></p>
          </li>
	         <li class="timeline_right setScMc t2003">
	          <p class="timeline_year"><span class="yearM">2003</span></p>
	          <p class="timeline_ttl"><span class="ttlM">Using pharmaceutical expertise to support health through food products</span></p>
	          <p class="timeline_text"><span>Even as modern life grows richer, lack of exercise and irregular eating habits drive increased incidence of lifestyle diseases. To address this challenge to society in our capacity as a drug manufacturer, we launched Livita, a food and supplement brand covering every area of health. Our goal with Livita is to support people with product development based on safety and effectiveness. Following the launch of this brand, we began reinforcing our development of food and supplements as a peripheral part of our self-medication business.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_2003.jpg" alt="Livita"/></p>
          </li>
	         <li class="timeline_left setScMc t2005-01 lineS">
	          <p class="timeline_year"><span class="yearS">2005</span></p>
	          <p class="timeline_text"><span>Release of RiUP Lady, a hair regrowth treatment for women, in response to demand from women struggling with hair issues.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_2005.jpg" alt="RiUP Lady"/></p>
          </li>
	         <li class="timeline_right setScMc t2005-02">
	          <p class="timeline_year"><span class="yearS">2005</span></p>
	          <p class="timeline_text"><span>Release of Pabron<sup>&trade;</sup> and Taisho Kampo<sup>&trade;</sup> in Thailand, part of our strategy of using our know-how gained in Japan to develop our OTC drug business in Asia.</span></p>
	          <p class="timeline_img"><img src="img/history_2005_02.jpg" alt="Pabron&trade;, Taisho Kampo&trade; (Thailand)"/></p>
          </li>
	         <li class="timeline_left setScMc t2006-01 lineM">
	          <p class="timeline_year"><span class="yearM">2006</span></p>
	          <p class="timeline_ttl"><span class="ttlM">Launch of Taisho Direct and more proactive information-sharing</span></p>
	          <p class="timeline_text"><span>In response to changes in consumer buying patterns, and to create new sales opportunities, we launched the direct-to-consumer sales website Taisho Direct. Through Taisho Direct, we put even greater effort into sharing clear and simple information with consumers, offering helpful advice and explaining product benefits based on scientific data.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_2006.jpg" alt="Taisho Direct"/></p>
          </li>
	         <li class="timeline_right setScMc t2006-02">
	          <p class="timeline_year"><span class="yearS">2006</span></p>
	          <p class="timeline_text"><span>Release of Pabron<sup>&trade;</sup> and Taisho Kampo<sup>&trade;</sup> in Malaysia. The Pabron series continues to grow, targeting specific symptoms.</span></p>
	          <p class="timeline_img"><img src="img/history_2006_02.jpg" alt="Pabron&trade;, Taisho Kampo&trade; (Malaysia)"/></p>
          </li>
	         <li class="timeline_left setScMc t2007 lineS">
	          <p class="timeline_year"><span class="yearS">2007</span></p>
	          <p class="timeline_text"><span>Release of Geninax<sup>&reg;</sup> Tablet, a quinolone oral anti-bacterial agent.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_2007.jpg" alt="Geninax&reg; Tablet"/></p>
          </li>
	         <li class="timeline_right setScMc t2008-01">
	          <p class="timeline_year"><span class="yearS">2008</span></p>
	          <p class="timeline_text"><span>In conjunction with the Isetan department store, we released hisoca, a concentrated herbal beverage developed through extended research on traditional East Asian medicinal components and herbs.<br>
			  This product has found many loyal buyers among beauty-conscious women.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_2008.jpg" alt="hisoca"/></p>
          </li>
	         <li class="timeline_left setScMc t2008-02 lineM">
	          <p class="timeline_year"><span class="yearM">2008</span></p>
	          <p class="timeline_ttl"><span class="ttlM">Obtaining a top brand in the intestinal field</span></p>
	          <p class="timeline_text"><span>Acquisition of Biofermin Pharmaceutical, maker of Biofermin<sup>&reg;</sup>, as a consolidated subsidiary. This allowed us to enter the field of intestinal medicine for the first time with Japan&rsquo;s top brand in that category.</span></p>
	          <p class="timeline_img img_s"><img src="img/history_2008_02.jpg" alt="Biofermin&reg;"/></p>
          </li>
	         <li class="timeline_right setScMc t2008-03">
			  <p class="timeline_year color02"><span class="timeline_text">2008 &nbsp;Global Financial Crisis</span></p>
          </li>
	         <li class="timeline_right setScMc t2009">
	          <p class="timeline_year"><span class="yearL">2009</span></p>
	          <p class="timeline_ttl"><span class="ttlL">We entered the Asia ex-Japan OTC drug market</span></p>
	          <p class="timeline_text"><span>To strengthen the position of the Self-Medication Operations Group in Asia ex-Japan, which is expected to enjoy brisk growth in this region, Taisho Pharmaceutical purchased the trademarks for certain OTC drugs held by US-based Bristol-Myers Squibb (BMS) in the region and acquired PT Bristol-Myers Squibb Indonesia Tbk (BMSI) as a consolidated subsidiary.</span></p>
          </li>
	         <li class="timeline_left setScMc t2011-01 lineXL">
			  <p class="timeline_year color02"><span class="timeline_text">2011 &nbsp;Great East Japan Earthquake and Tsunami</span></p>
          </li>
	         <li class="timeline_left setScMc t2011-02 lineM">
	          <p class="timeline_year"><span class="yearM">2011</span></p>
	          <p class="timeline_text"><span>Release of the osteoporosis agent Edirol<sup>&reg;</sup> Capsule, developed jointly with Chugai Pharmaceutical. This was the first time in 22 years that an activated vitamin D3 agent was released in Japan as a new drug.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_2011.jpg" alt="Edirol&reg; Capsule"/></p>
          </li>
	         <li class="timeline_right setScMc t2011-03">
	          <p class="timeline_year"><span class="yearM">2011</span></p>
	          <p class="timeline_ttl"><span class="ttlM">Expanding our business base in Asia through M&amp;As</span></p>
	          <p class="timeline_text"><span>We acquired all the shares of Malaysia&rsquo;s HOE (Hoepharma Holdings Sdn. Bhd.), which has the top share of that country&rsquo;s prescription dermatological treatment market. HOE also sells products in 40 countries in and around Asia. This M&amp;A helped our self-medication business make a major advance into Malaysia, expanding our business base in the Asian region.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_2011_02.jpg" alt="Hoepharma Holdings Sdn. Bhd."/></p>
          </li>
	         <li class="timeline_left setScMc t2011-04 lineM">
	          <p class="timeline_year"><span class="yearM">2011</span></p>
	          <p class="timeline_ttl"><span class="ttlM">Acquiring major brands in Southeast Asia</span></p>
	          <p class="timeline_text"><span>To cultivate the Southeast Asian market further, we acquired US company Johnson &amp; Johnson&rsquo;s brand equity in motion sickness medications Bonamine<sup>&reg;</sup> and Dramamine<sup>&reg;</sup> in the Philippines, Indonesia, and Thailand.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_2011_03.jpg" alt="Bonamine&reg;"/></p>
          </li>
	         <li class="timeline_right setScMc t2011-05">
	          <p class="timeline_year"><span class="yearS">2011</span></p>
	          <p class="timeline_text img_m"><span>Establishment of Taisho Pharmaceutical Holdings with the aim of achieving sustained growth both domestically and internationally. We continue to refine our group structure.</span></p>
          </li>
	         <li class="timeline_left setScMc t2012-01 lineS">
	          <p class="timeline_year"><span class="yearS">2012</span></p>
	          <p class="timeline_text"><span>Acquisition of Japanese pharmaceutical manufacturer Tokuhon Corporation as a wholly owned subsidiary. The corporate structure lets us make full use of Tokuhon&rsquo;s experience in the topical medication market, both OTC and prescription.</span></p>
	          <p class="timeline_img"><img src="img/history_2012.jpg" alt="Tokuhon"/></p>
          </li>
	         <li class="timeline_right setScMc t2012-02">
	          <p class="timeline_year"><span class="yearM">2012</span></p>
	          <p class="timeline_ttl"><span class="ttlM">Expanding our business in North America</span></p>
	          <p class="timeline_text img_m"><span>In Mexico, where we had been selling energy drinks since 2002, we acquired four local pharmaceutical companies, including CICSA, as part of our first major foray into the OTC drug market there. CICSA&rsquo;s sales network and manufacturing facilities helped us to expand our business elsewhere in the North American region as well.</span></p>
          </li>
	         <li class="timeline_left setScMc t2012-03 lineM">
	          <p class="timeline_year"><span class="yearM">2012</span></p>
	          <p class="timeline_ttl"><span class="ttlM">Reinforcing our foundations in Thailand</span></p>
	          <p class="timeline_text"><span>We merged our Thai-based OTC drug business with that of Osotspa, a partner in our energy drink business. The resulting company, Taisho Osotspa Pharmaceutical, continues to develop its business along the two lines of energy drinks and OTC drugs.</span></p>
          </li>
	         <li class="timeline_right setScMc t2012-04">
	          <p class="timeline_year"><span class="yearS">2012</span></p>
	          <p class="timeline_text"><span>Acquisition of UV care brand Coppertone<sup>&reg;</sup>, developed by US company Schering-Plough but well known in Japan as well.</span></p>
	          <p class="timeline_img img_s"><img src="img/history_2012_02.jpg" alt="Coppertone&reg;"/></p>
          </li>
	         <li class="timeline_left setScMc t2013-01 lineS">
	          <p class="timeline_year"><span class="yearS">2013</span></p>
	          <p class="timeline_text"><span>Release of Epadel T, a treatment for improving abnormal triglyceride levels, following conclusion of a sales contract with Mochida Pharmaceutical.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_2013.jpg" alt="Epadel T"/></p>
          </li>
	         <li class="timeline_right setScMc t2013-02">
	          <p class="timeline_year"><span class="yearM">2013</span></p>
	          <p class="timeline_ttl"><span class="ttlM">Meeting the needs of an aging society with osteoporosis treatments</span></p>
	          <p class="timeline_text"><span>Released Bonviva<sup>&reg;</sup> IV Injection, a bisphosphonate osteoporosis treatment that can increase bone mass and prevent breaks with just one dose per month. This drug was developed jointly with Chugai Pharmaceutical.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_2013_02.jpg" alt="Bonviva&reg; IV Injection"/></p>
          </li>
	         <li class="timeline_left setScMc t2014-01">
	          <p class="timeline_year"><span class="yearL">2014</span></p>
	          <p class="timeline_ttl"><span class="ttlL">Contributing to early treatment of type 2 diabetes with a treatment developed in-house</span></p>
	          <p class="timeline_text"><span>Seven years after we began research into diabetes treatments, we released Lusefi<sup>&reg;</sup> Tablet, a treatment we created, developed, and gained approval to manufacture and sell. Lusefi is an SGLT2 inhibitor that lowers blood glucose levels by increasing urinary glucose excretion.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_2014.jpg" alt="Lusefi&reg;"/></p>
          </li>
	         <li class="timeline_right setScMc t2014-02">
	          <p class="timeline_year"><span class="yearM">2014</span></p>
	          <p class="timeline_ttl"><span class="ttlM">Acquiring a powerful brand presence in the Philippines</span></p>
	          <p class="timeline_text"><span>Acquired Philippine brand equity and trademark rights to Flanax<sup>&reg;</sup>, an anti-inflammatory analgesic from Swiss company Roche.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_2014_02.jpg" alt="Flanax&reg;"/></p>
          </li>
	         <li class="timeline_left setScMc t2014-03 lineS">
	          <p class="timeline_year"><span class="yearS">2014</span></p>
	          <p class="timeline_text"><span>Released COBARASAPŌTO, a weight loss support drink in the health food domain of our self-medication business. In 2015, one year later, we released the carbonated energy drink RAIZIN.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_2014_03.jpg" alt="COBARASAPŌTO, RAIZIN"/></p>
          </li>
	         <li class="timeline_right setScMc t2016-01">
	          <p class="timeline_year"><span class="yearS">2016</span></p>
	          <p class="timeline_text img_m"><span>Acquisition of shares in Dr. Program, a cosmetics manufacturer.</span></p>
          </li>
	         <li class="timeline_left setScMc t2016-02 lineM">
	          <p class="timeline_year"><span class="yearM">2016</span></p>
	          <p class="timeline_ttl"><span class="ttlM">Improving quality of life with pain-relieving patches</span></p>
	          <p class="timeline_text"><span>Following a joint development project with Group company Tokuhon we released LOQOA<sup>&reg;</sup> Tape, an externally applied treatment for osteoarthritis.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_2016.jpg" alt="LOQOA&reg; tape"/></p>
          </li>
	         <li class="timeline_right setScMc t2017">
	          <p class="timeline_year"><span class="yearS">2017</span></p>
	          <p class="timeline_text"><span>Release of Claritin<sup>&reg;</sup> EX, a switch OTC rhinitis treatment based on globally available drug Loratadine. Claritin EX contains the same quantities and components as a prescription pharmaceutical.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_2017.jpg" alt="Claritin&reg; EX"/></p>
          </li>
	         <li class="timeline_left setScMc t2019-01">
	          <p class="timeline_year"><span class="yearL">2019</span></p>
	          <p class="timeline_ttl"><span class="ttlL">Further strengthening our prescription drug business in Asia</span></p>
	          <p class="timeline_text"><span>To improve our international competitiveness, in 2016 we acquired a stake in the Vietnamese drug manufacturer Duoc Hau Giang Pharmaceutical JSC (DHG). Aiming to further strengthen our prescription pharmaceutical business in the Asian market, we made DHG a consolidated subsidiary by additional stake acquisition in 2019.</span></p>
	          <p class="timeline_img"><img src="img/2019_01-20201109.jpg" alt="Duoc Hau Giang Pharmaceutical JSC"/></p>
          </li>
	         <li class="timeline_right setScMc t2019-02">
	          <p class="timeline_year"><span class="yearM">2019</span></p>
	          <p class="timeline_ttl"><span class="ttlM">Cultivating the skincare field</span></p>
	          <p class="timeline_text"><span>In 2018 we established Taisho Beauty Online, a site offering a wide range of products from beauty supplements to cosmetics. We also released the new whitening and moisturizing skincare brand AdryS, further extending our support for women&rsquo;s beauty and health.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_2019_02.jpg" alt="AdryS"/></p>
          </li>
	         <li class="timeline_left setScMc t2019-03">
	          <p class="timeline_year"><span class="yearL">2019</span></p>
	          <p class="timeline_ttl"><span class="ttlL">Securing a firm business foundation in Europe</span></p>
	          <p class="timeline_text"><span>We became stakeholders in the French company UPSA, which has some of the leading products in the analgesic and cold medicine categories. This gave us a strong foothold in Europe, complementing our existing business base in Japan and Southeast Asia.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_2019_03.jpg" alt="UPSA"/></p>
          </li>
	         <li class="timeline_right setScMc t2020-01">
	          <p class="timeline_year"><span class="yearM">2020</span></p>
	          <p class="timeline_text"><span>From the Lipovitan brand, we launched Lipovitan Jelly, a convenient way of boosting one' energy amid daily life, and Lipovitan DX, a tablet-type quasi-drug for recovering from fatigue.</span></p>
	          <p class="timeline_img img_m"><img src="img/history_2020_01.jpg" alt="lipovitanDX"/></p>
          </li>
         </ul>
	        <div class="timelineBrmArw"></div>
        </div>
	       <div class="boxIcnBtn">
	        <div class="boxIcnTxt"><span class="txtClose">CLOSE</span></div>
	        <div class="boxIcn"></div>
        </div>
       </div>
      </div>
     </dd>
    </dl>
   </div>
  </section>
 </main>
	<!-- //contents --> 
	<!-- footer --> 
	<div id="footerWrap">
	<footer id="footer">
		<div id="footerInner">
			<ul>
				<li><a href="../privacy/index.html">Privacy</a></li>
				<li><a href="../site_policy/index.html">Site Policy</a></li>
				<li><a href="../web_accessibility/index.html">Web Accessibility</a></li>
				<li><a href="../sitemap/index.html">Sitemap</a></li>
			</ul>
			<p class="btn"><a href="https://www.taisho-holdings.co.jp/" target="_blank">Taisho Pharmaceutical Holdings (Japanese)</a></p>
			<p class="copyright">&copy; Taisho Pharmaceutical Holdings Co., Ltd.<span>&nbsp;All Rights Reserved.&nbsp;</span></p>
		</div>
		<div id="ftr-pagetop">
			<div class="boxContents">
				<p><a href="#header"><span>Back to top</span></a></p>
			</div>
		</div>
	</footer>
</div>
	<!-- //footer --> 
</div>
<!-- //container -->

<script src="../shared/js/jquery.js"></script> 
<script src="../shared/js/common.js"></script> 
<script src="../shared/js/analytics.js"></script>

<script type="text/javascript" src="js/history.js"></script>


</body>

<!-- Mirrored from www.taisho.co.jp/global/who_we_are/history.html by HTTrack Website Copier/3.x [XR&CO'2014], Sun, 16 Oct 2022 12:05:00 GMT -->
</html>